A Combination of Avelumab and Taxane (AVETAX) for Urothelial Cancer

Clinical trial NCT03575013 · COMPLETED

Trial details

NCT number: NCT03575013
Sponsor: Yousef Zakharia
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Urothelial Carcinoma

Start date: 2018-10-29
Primary completion: 2021-12-15
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.